17:21:12United States

Opus Genetics, Inc. (IRD)

NASDAQ

Key stats Fiscal year 2025

Income statement

Revenue
14,196,000 29.1%
Net income
-49,591,000
Operating income
-38,599,000
Earnings per share
-0.80

Growth and profitability

Operating margin
-271.90
Net margin
-349.33
Return on equity
-323.11
Return on assets
-98.70

Balance sheet

Total assets
50,243,000
Total liabilities
34,895,000
Shareholders' equity
15,348,000
Cash and equivalents
45,091,000
Debt
1,129,000
Net debt
-43,962,000
Current ratio
6.43
Debt to equity
0.07

Cash flow and ratios

Operating cash flow
-35,253,000

Shareholder returns

Shares outstanding
96,654,336
Book value per share
0.16
Revenue and net income
From revenue to profit 2025
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Durham, NC
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Opus Genetics, Inc. trades on NASDAQ under the ticker symbol IRD. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis